Rebif Pages on BioPortfolio:

Rebif Beats Avonex In Head-To-Head Trial
Rebif is approved in over 70 countries, but had not been marketed in the U.S. ... As both Rebif and Avonex will now compete in the U.S., Rebif's advantage ...
http://www.bioportfolio.com/news/btech_041802_2.htm...

BioPortfolio Biotechnology BioNews : live article
During 2006, combined sales estimates of FDA-approved injectable MS therapies, which include Avonex®, Betaseron®, Copaxone®, and Rebif®, ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

Biotech Tracker News - Suboptimal Study Suggests Rebif Advantage ...
26 Nov 2002 ... Therefore, these analyses are not likely to benefit Rebif strongly, although they also will not shift momentum back towards Avonex. ...
http://www.bioportfolio.com/news/biotracker_30.htm...

BioPortfolio.com - BioWeb Lymphopenia Search
Medical Officer s Clinical Review - Interferon beta-1a, Rebif, Serono Incorporated page 49 author: CBER. Matching: lymphopenia, Find similar documents
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Rebif
Rebif - BioPortfolio - Indepth. ... Rebif. Interferon Beta-1a. Download PDF containing detailed information. PDF Version ...
http://www.bioportfolio.com/indepth/Rebif.html...

BTG plc: Final Phase II Results of CampathR Multiple Sclerosis ...
23 Oct 2008 ... The CARE-MS I Phase 3 study (Comparison of Alemtuzumab and Rebif ... The trial compared the efficacy of alemtuzumab with Rebif using two ...
http://www.bioportfolio.com/biotech_news/BTG_11.htm...

BioPortfolio Bulletin - November 27 2002
Suboptimal Study Suggests Rebif Advantage Over Avonex · Zavesca Approved in Europe · Zavesca's Second Chance Type I Gaucher disease · Aldurazyme Should be
...
http://www.bioportfolio.co.uk/bulletin_12.htm...

Promising Antegren data ruffles Serono
This compares favorably to the 54% relapse rate recently reported for Rebif; however, this was over a two-year treatment period. ...
http://www.bioportfolio.com/news/datamonitor_100.htm...

Avonex Is Not an Orphan Any More
Rebif is approved in over 70 countries, but has not been marketed in the U.S. because of Avonex's orphan drug exclusivity through May 2003. ...
http://www.bioportfolio.com/news/btech_031102_1.htm...

Results from other life science and pharmaceutical sites:

Interferon beta-1a - Wikipedia, the free encyclopedia
A one month supply of Avonex or Rebif can cost anywhere from $1600 to more ... Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in ...
http://en.wikipedia.org/wiki/Interferon_beta-1a...

REBIF | Industry information for REBIF
Rebif should be used with caution in patients with depression, preexisting seizure disorders, and hepatic dysfunction. The potential for liver injury
should ...
http://www.medscape.com/infosite/rebif...

Rebif | Pfizer: the world's largest research-based pharmaceutical ...
Information on the Pfizer product Rebif. ... To learn more about this medication , visit the REBIF consumer Web site. Visit www.rebif.com ...
http://www.pfizer.com/products/rx/rx_product_rebif.jsp...

REBIF | Industry information for REBIF
Watch a short video that shows how simple it is for patients to prepare their Rebif injection, compared to the number of steps required to prepare ...
http://www.medscape.com/infosite/rebif/article-9...

Medication Guide Rebif (Re-bif)
What is Rebif о ? Rebif о is a type of protein called beta interferon that occurs ... Your doctor will tell you what dose of Rebif to use, and may change
...
http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089019.pdf...

REBIF | Industry information for REBIF
Significantly fewer combined unique active MRI lesions with Rebif 44 mcg tiw than with placebo (32% vs 55%mean active scans per patient; P=0.0008)1,2‡ ...
http://www.medscape.com/infosite/rebif/article-1...

Rebif by Serono, Marketed in India by Serum Institute of India
Rebif Marketed Product of Serum Institute of India Ltd.
http://www.seruminstitute.com/content/products/product_rebif...

Merck Serono S.A. - Rebif
Rebif® (interferon beta-1a) is a disease modifying drug (DMD) used to treat relapsing forms of multiple sclerosis (MS). It is identical to the interferon
...
http://www.merckserono.net/en/therapeutic_areas/neurodegener...

REBIF | Industry information for REBIF
In the head-to-head EVIDENCE study, superior relapse outcomes were observed over an average of 64 weeks with Rebif 44 mcg tiw vs Avonex 30 mcg qw1 ...
http://www.medscape.com/infosite/rebif/article-4...

Local pain during REBIF injection is not due to acidic pH
PubMed related articles. [PRISMS Study. Interferon-beta 1a (Rebif) in relapsing multiple sclerosis]. Nervenarzt. 1999 Feb; 70(2):182-5. [Nervenarzt. 1999] ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1739129/...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.